CD276 and head and neck squamous cell carcinoma: In the present study, we describe both analyses of clinical data and preclinical HNSCC mouse model testing the hypothesis that blocking B7‐H3 could perform an antitumour function by increasing IFN‐γ+CD8+ T cells.